Simultaneous use of DGGE and DHPLC to screen TP53 mutations in cancers of the esophagus and cardia from a European high incidence area (Lower Normandy, France)

Mutagenesis

Volumn 18, Issue 3, 2003, Pages 299-306

  Breton, Jean ^c   Sichel, François ^c   Abbas, Ahmed ^c   Marnay, Jacques ^a   Arsène, Dominique ^b   Lechevrel, Mathilde ^c  

^a CENTRE FRANÇOIS BACLESSE   (France)

^b CHU CÔTE DE NACRE   (France)

^c UNIVERSITÉ DE CAEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; ADENINE; BENZO[A]PYRENE; GUANINE; NITROSAMINE; PROTEIN P53; THYMINE; TOBACCO SMOKE;

ARTICLE; AUTOMATION; BARRETT ESOPHAGUS; BEVERAGE; CANCER INCIDENCE; CARDIA CARCINOMA; CONTROLLED STUDY; CPG ISLAND; ESOPHAGUS CARCINOMA; FRANCE; FREQUENCY ANALYSIS; GASTROESOPHAGEAL REFLUX; GEL ELECTROPHORESIS; GENETIC POLYMORPHISM; GENETIC SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INFLAMMATORY DISEASE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MELTING POINT; MUTATIONAL ANALYSIS; NUCLEIC ACID BASE SUBSTITUTION; POINT MUTATION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; SOMATIC MUTATION; SQUAMOUS CELL CARCINOMA;

CARDIA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESOPHAGEAL NEOPLASMS; FRANCE; HUMANS; MUTATION; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

NICOTIANA TABACUM;

EID: 0038393128     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/18.3.299     Document Type: Article

References (41)

1. Ambs.S., Hussain,S.P. and Harris,C.C. (1997) Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J., 11, 443-448.
2. Audrézet,M.P., Robaszkiewicz,M., Mercier,B., Nousbaum,J.B., Bail,J.P., Hardy,E., Volant,A., Lozac'h,P., Charles,J.F. and Gouérou,H. (1993) TP53 gene mutation profile in esophageal squamous cell carcinomas. Cancer Res., 53, 5745-5749.
3. Biramijamal,F, Allameh,A., Mirbod,P., Groene,H.J., Koomagi,R. and Hollstein,M. (2001) Unusual profile and high prevalence of p53 mutations in esophageal squamous cell carcinomas from northern Iran. Cancer Res., 61, 3119-3123.
4. Botterweck,A.A., Schouten,L.J., Volovics,A., Dorant,E. and van den Brandt,P.A. (2000) Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int. J. Epidemiol., 29, 645-654.
5. Denissenko,M.F., Pao,A., Pfeifer,G.P. and Tang,M. (1998) Slow repair of bulky DNA adducts along the non-transcribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers. Oncogene, 16, 1241-1247.
6. Dolan,K., Sutton,R., Walker,S.J., Morris,A.I., Campbell,F. and Williams,E.M. (1999) New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology. Br J. Cancer, 80, 834-842.
7. Fléjou,J.F., Gratio,V.. Muzeau,F. and Hamelin,R. (1999) p53 abnormalities in adenocarcinoma of the gastric cardia and antrum. Mol. Pathol., 52, 263-268.
8. Gleeson,C.M., Sloan,J.M., McManus,D.T., Maxwell,P., Arthur,K., McGuigan,J.A., Ritchie,A.J. and Russell,S.E. (1998) Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia. Br. J. Cancer, 77, 277-286.
9. Gross,E., Kiechle,M. and Arnold,N. (2001) Mutation analysis of p53 in ovarian tumors by DHPLC. J. Biochem. Biophys. Methods, 47, 73-81.
10. Hamelin,R., Jego,N., Laurent- Puig,P., Vidaud,M. and Thomas,G. (1993) Efficient screening of p53 mutations by denaturing gradient gel electrophoresis in colorectal tumors. Oncogene. 8, 2213-2220.
11. Hollstein,M.C., Peri,L., Mandard,A.M., Welsh,J.A., Montesano,R., Metcalf,R.A., Bak,M. and Harris,C.C. (1991) Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res., 51, 4102-4106.
12. Hu,N., Huang,J., Emmert-Buck,M.R. et al. (2001) Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China. Clin. Cancer Res., 7, 883-891.
13. Ireland,A.P., Shibata,D.K., Chandrasoma,P., Lord,R.V, Peters,J.H. and DeMeester,T.R. (2000) Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia. Ann. Surg., 231, 179-187.
14. Jones,A.C., Sampson,J.R. and Cheadle,J.P. (2001) Low level mosaicism detectable by DHPLC but not by direct sequencing. Hum. Mutat., 17, 233-234.
15. Keller,G., Hartmann,A., Mueller,J. and Hofler,H. (2001) Denaturing high pressure liquid chromatography (DHPLC) for the analysis of somatic p53 mutations. Lab. Invest., 81, 1735-1737.
16. Kourkine,I.V, Hestekin,C.N., Buchholz,B.A. and Barron,A.E. (2002) High-throughput, high-sensitivity genetic mutation detection by tandem single-strand conformation polymorphism/heteroduplex analysis capillary array electrophoresis. Anal. Chem., 74, 2565-2572.
17. Kropveld,A., Rozemuller,E.H., Leppers,F.G., Scheidel,K.C., de Weger,R.A., Koole,R., Hordijk,G.J., Slootweg,P.J. and Tilanus,M.G. (1999) Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers. Lab. Invest., 79, 347-353.
18. Launoy,G., Milan,C., Day,N.E., Faivre,J., Pienkowski,P. and Gignoux,M. (1997) Oesophageal cancer in France: potential importance of hot alcoholic drinks. Int. J. Cancer, 71, 917-923.
19. Launoy,G., Milan,C., Day,N.E., Pienkowski,M.P., Gignoux,M. and Faivre,J. (1998) Diet and squamous-cell cancer of the oesophagus: a French multicentre case-control study. Int. J. Cancer, 76, 7-12.
20. Leonard,D.G., Travis,L.B., Addya,K. et al. (2002) p53 mutations in leukemia and myelodysplastic syndrome after ovarian cancer. Clin. Cancer Res., 8, 973-985.
21. Liang,Y.Y., Esteve,A., Martel-Planche,G., Takahashi,S., Lu,S.H., Montesano,R. and Hollstein,M. (1995) p53 mutations in esophageal tumors from high-incidence areas of China. Int. J. Cancer, 61, 611-614.
22. Marnett,L.J. (2000) Oxyradicals and DNA damage. Carcinogenesis, 21, 361-370.
23. Montesano,R. and Hainaut,P. (1998) Molecular precursor lesions in oesophageal cancer. Cancer Surv., 32, 53-68.
24. Moyret,C., Theillet,C., Puig,P.L., Moles,J.P., Thomas,G. and Hamelin,R. (1994) Relative efficiency of denaturing gradient gel electrophoresis and single strand conformation polymorphism in the detection of mutations in exons 5 to 8 of the p53 gene. Oncogene, 9, 1739-1743.
25. Muzeau,F., Fléjou,J.F., Potet,F., Belghiti,J., Thomas,G. and Hamelin,R. (1996) Profil des mutations du gène p53 et expression anormale de la protéine p53 dans les deux formes de cancer de l'oesophage. Gastroenterol. Clin. Biol., 20, 430-437.
26. Noori,P. and Hou,S.M. (2001) Mutational spectrum induced by acetaldehyde in the HPRT gene of human T lymphocytes resembles that in the p53 gene of esophageal cancers. Carcinogenesis, 22, 1825-1830.
27. Oefner,P.J. and Underhill,P.A. (1995) Comparative DNA sequencing by denaturing high-performance liquid chromatography. Am. J. Hum. Genet., 57, A266.
28. Olivier,M., Eeles,R., Hollstein,M., Khan,M.A., Harris,C.C. and Hainaut,P. (2002) The IARC TP53 database: new online mutation analysis and recommendations to users. Hum. Mutat., 19, 607-614.
29. Parkin,D.M. (2001) Global cancer statistics in the year 2000. Lancet Oncol., 2, 533-543.
30. Putz,A., Hartmann,A.A., Fontes,P.R., Alexandre,C.O., Silveira,D.A., Klug,S.J. and Rabes,H.M. (2002) TP53 mutation pattern of esophageal squamous cell carcinomas in a high risk area (Southern Brazil): role of life style factors. Int. J. Cancer, 98, 99-105.
31. Robert,V., Michel,P., Flaman,J.M., Chiron,A., Martin,C., Charbonnier,F., Paillot,B. and Frebourg,T. (2000) High frequency in esophageal cancers of p53 alterations inactivating the regulation of genes involved in cell cycle and apoptosis. Carcinogenesis, 21, 563-565.
32. Schneider,P.M., Stoeltzing,O., Roth,J.A., Hoelscher,A.H., Wegerer,S., Mizumoto,S., Becker,K., Dittler,H.J., Fink,U. and Siewert,J.R. (2000) P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus. Clin. Cancer Res., 6, 3153-3158.
33. Semenza,J.C. and Weasel,L.H. (1997) Molecular epidemiology in environmental health: the potential of tumor suppressor gene p53 as a biomarker. Environ. Health Perspect., 105 (suppl. 1), 155-163.
34. Siewert,J.R. and Stein,H.J. (1996) Carcinoma of the cardia: carcinoma of the gastroesophageal junction-classification, pathology and extent of resection. Dis. Esophagus, 9, 173-182.
35. Sigal,A. and Rotter,V. (2000) Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. Cancer Res., 60, 6788-6793.
36. Smith,L.E., Denissenko,M.F., Bennett,W.P., Li,H., Amin,S., Tang,M. and Pfeifer,G.P. (2000) Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons. J. Natl Cancer Inst., 92, 803-811.
37. Tanière,P., Martel-Planche,G., Saurin,J.C., Lombard-Bohas,C., Berger,F., Scoazec,J.Y. and Hainaut,P. (2001) TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in western Europe. Br. J. Cancer, 85, 721-726.
38. Trulzsch,B., Krohn,K., Wonerow,P. and Paschke,R. (1999) DGGE is more sensitive for the detection of somatic point mutations than direct sequencing. Biotechniques, 27, 266-268.
39. Vogelstein,B. and Kinzler,K.W. (1992) p53 function and dysfunction. Cell, 70, 523-526.
40. Wang,D., Weghorst,C.M., Calvert,R.J. and Stoner,G.D. (1996) Mutation in the p53 tumor suppressor gene in rat esophageal papillomas induced by N-nitrosomethylbenzylamine. Carcinogenesis, 17, 625-630.
41. Xiao,W. and Oefner,P.J. (2001) Denaturing high-performance liquid chromatography: a review. Hum. Mutat., 17, 439-474.